glp-1 indigestion 6 Common Side Effects of Taking Medication GLP-1 Side Effects: Acid Reflux

In late-stage trials, people taking orforglipron lost an average of about 12% of their body weight over roughly 72 weeks , and head-to-head studies suggest it may outperform standard oral semaglutide tablets (Rybelsus) in both weight loss and blood sugar control

Dealing with limited overlap in estimation of average treatment effects

And because Wegovy is FDA-approved to reduce the risk for serious heart problems in people with obesity or overweight, this can be a loophole

Knowing what to expect matters, especially if you are weighing one against the other

Patients can change their injection day if needed, ensuring at least 3 days between doses